Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.02 USD | +2.26% | +1.89% | +3.05% |
06-05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
06-05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.05% | 3.9B | |
+4.57% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
+3.60% | 8.97B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Axsome Therapeutics Insider Sold Shares Worth $2,257,449, According to a Recent SEC Filing